Leukemia immune profiles predict drug resistance and benefits of immunotherapy

(American Association for the Advancement of Science) By analyzing 442 samples from three groups of children and adults with acute myeloid leukemia (AML), researchers have identified new immune classes of the disease that predict the likelihood of drug resistance and positive responses to immunotherapy.